Safety and Efficacy of AIN457 in Patients With Active Non-infectious Uveitis

Novartis Investigative Site, Lausanne

Novartis Investigative Site, Budapest

Novartis Investigative Site, Bern

Novartis Investigative Site, Bern

Novartis Investigative Site, Lucerne

Novartis Investigative Site, Sankt Gallen

Novartis Investigative Site, Slingerlands

Novartis Investigative Site, Afula

Novartis Investigative Site, Nantes

Novartis Investigative Site, Petah Tikva

Novartis Investigative Site, Ramat Gan

Novartis Investigative Site, Tel Aviv

Novartis Investigative Site, Arlington

Novartis Investigative Site, Houston

Novartis Investigative Site, Freiburg im Breisgau

Novartis Investigative Site, Beverly Hills

Novartis Investigative Site, Singapore

Novartis Investigative Site, Ahmedabad

Novartis Investigative Site, Cambridge

Novartis Investigative Site, London

Novartis Investigative Site, North York

Novartis Investigative Site, Montreal

Novartis Investigative Site, Cairo

Novartis Investigative Site, Göttingen

Novartis Investigative Site, Fukuoka

Novartis Investigative Site, Fukushima

Novartis Investigative Site, Sapporo

Novartis Investigative Site, Kyoto

Novartis Investigative Site, Osaka

Novartis Investigative Site, Suita

Novartis Investigative Site, Shimotsuka-gun

Novartis Investigative Site, Bunkyo-ku

Novartis Investigative Site, Mitaka

Novartis Investigative Site, Barcelona

Novartis Investigative Site, Barcelona

Novartis Investigative Site, York